Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India Plans Taskforce To Deal With Pharmaceutical Environmental Issues

This article was originally published in PharmAsia News

Executive Summary

NEW DELHI - The Indian government will soon constitute a taskforce to assess the impact of drug manufacturing on the environment and find amicable solutions, Department of Pharmaceuticals Secretary Ashok Kumar announced Feb. 12 at an industry seminar in New Delhi
Advertisement

Related Content

The Environmental Cost Of Production: Will Big Pharma Be On The Hook For API Hazards?
The Environmental Cost Of Production: Will Big Pharma Be On The Hook For API Hazards?
The Environmental Cost Of Production: Will Big Pharma Be On The Hook For API Hazards?
The Environmental Cost Of Production: Will Big Pharma Be On The Hook For API Hazards?
Advertisement
UsernamePublicRestriction

Register

SC070762

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel